Descriptor English: | Pentylenetetrazole | ||||||
Descriptor Spanish: |
Pentilenotetrazol
| ||||||
Descriptor Portuguese: | Pentilenotetrazol | ||||||
Descriptor French: | Pentétrazol | ||||||
Entry term(s): |
Cardiazol Corasol Corazol Corazole Korazol Korazole Leptazole Metrazol Metrazole Pentamethylenetetrazole Pentazol Pentetrazole Pentylenetetrazol |
||||||
Tree number(s): |
D03.383.066.600 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D010433 | ||||||
Scope note: | A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Convulsants GABA Antagonists |
||||||
Registry Number: | WM5Z385K7T | ||||||
CAS Type 1 Name: | 5H-Tetrazolo(1,5-a)azepine, 6,7,8,9-tetrahydro- | ||||||
DeCS ID: | 10627 | ||||||
Unique ID: | D010433 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1966/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2013/07/08 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Pentylenetetrazole
- Preferred
Cardiazol
- Narrower
Corasol
- Narrower
Pentazol
- Narrower
Metrazol
- Narrower
Concept UI |
M0016203 |
Scope note | A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. |
Preferred term | Pentylenetetrazole |
Entry term(s) |
Leptazole Pentamethylenetetrazole Pentetrazole Pentylenetetrazol |
Concept UI |
M0373142 |
Preferred term | Cardiazol |
Concept UI |
M0373141 |
Preferred term | Corasol |
Entry term(s) |
Corazol Corazole Korazol Korazole |
Concept UI |
M0373139 |
Preferred term | Pentazol |
Concept UI |
M0373140 |
Preferred term | Metrazol |
Entry term(s) |
Metrazole |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey